ALTEOGEN revenue and financials

196170 · KRX · KRW

₩260,000.00Change from previous close: +0.19%Absolute change: +₩500.00

Close · October 6, 2026

In the fiscal year ended December 2025, ALTEOGEN reported revenue of ₩215.86B (+109.87% year over year). Net income was ₩141.67B, a net margin of 65.6%.

Annual revenue · 2025: ₩215.86B
  1. ₩28.81B2022
  2. ₩96.52B2023
  3. ₩102.85B2024
  4. ₩215.86B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+109.87%
2025 vs 2024
Net income growth
+127.57%
2025 vs 2024
Net margin
65.6%
2024: 60.5%

Financial data

Amounts in millions of KRW; per-share values in KRW; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total assets739,911729,470698,743639,477602,892—
Current assets521,872511,501480,795441,772408,102—
Cash and equivalents80,37042,27666,38151,71563,885—
Short-term investments366,469405,349363,641328,053322,771—
Inventory6,4256,1976,5306,6922,268—
Net property, plant and equipment55,95254,92440,87826,72921,404—
Goodwill—————113
Other intangible assets116,470118,338120,119119,516117,775—
Long-term investments918931931938944—
Current liabilities188,849212,396239,684256,390249,502—
Accounts payable1,0353,21411,1803,0791,219—
Long-term debt3,1943,6114,0284,4445,000—
Total debt7,0097,1127,0597,1757,138—
Total liabilities192,663216,612244,300261,555255,231—
Total equity (incl. minority)547,248512,858454,443377,922347,661—
Retained earnings378,651350,232218,538149,300126,955—
Minority interest10,7759,0779,2494,2044,167—